These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 1829098

  • 1. Response to steroid suppression in major depression resistant to antidepressant therapy.
    Murphy BE, Dhar V, Ghadirian AM, Chouinard G, Keller R.
    J Clin Psychopharmacol; 1991 Apr; 11(2):121-6. PubMed ID: 1829098
    [Abstract] [Full Text] [Related]

  • 2. Neuroendocrine responses to inhibitors of steroid biosynthesis in patients with major depression resistant to antidepressant therapy.
    Murphy BE, Ghadirian AM, Dhar V.
    Can J Psychiatry; 1998 Apr; 43(3):279-86. PubMed ID: 9561317
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial.
    Jahn H, Schick M, Kiefer F, Kellner M, Yassouridis A, Wiedemann K.
    Arch Gen Psychiatry; 2004 Dec; 61(12):1235-44. PubMed ID: 15583115
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol--a double-blind multicenter trial.
    Künzel HE, Ackl N, Hatzinger M, Held K, Holsboer-Trachsler E, Ising M, Kaschka W, Kasper S, Konstantinidis A, Sonntag A, Uhr M, Yassouridis A, Holsboer F, Steiger A.
    J Psychiatr Res; 2009 Apr; 43(7):702-10. PubMed ID: 19038406
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cortisol synthesis inhibition: a new treatment strategy for the clinical and endocrine manifestations of depression.
    Thakore JH, Dinan TG.
    Biol Psychiatry; 1995 Mar 15; 37(6):364-8. PubMed ID: 7772644
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clinical characteristics and treatment outcome in a representative sample of depressed inpatients - findings from the Munich Antidepressant Response Signature (MARS) project.
    Hennings JM, Owashi T, Binder EB, Horstmann S, Menke A, Kloiber S, Dose T, Wollweber B, Spieler D, Messer T, Lutz R, Künzel H, Bierner T, Pollmächer T, Pfister H, Nickel T, Sonntag A, Uhr M, Ising M, Holsboer F, Lucae S.
    J Psychiatr Res; 2009 Jan 15; 43(3):215-29. PubMed ID: 18586274
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Limbic-hypothalamic-pituitary-adrenal axis in depression: literature review].
    Twardowska K, Rybakowski J.
    Psychiatr Pol; 1996 Jan 15; 30(5):741-55. PubMed ID: 8984515
    [Abstract] [Full Text] [Related]

  • 16. Pituitary-adrenal cortical axis measures as predictors of sustained remission in major depression.
    O'Toole SM, Sekula LK, Rubin RT.
    Biol Psychiatry; 1997 Jul 15; 42(2):85-9. PubMed ID: 9209724
    [Abstract] [Full Text] [Related]

  • 17. Treatment of major depression with steroid suppressive drugs.
    Murphy BE.
    J Steroid Biochem Mol Biol; 1991 Aug 15; 39(2):239-44. PubMed ID: 1888684
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.